ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+20.9%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$277M
AUM Growth
+$25.7M
(+10%)
Cap. Flow
-$22M
Cap. Flow
% of AUM
-7.94%
Top 10 Holdings %
Top 10 Hldgs %
64.04%
Holding
71
New
16
Increased
8
Reduced
11
Closed
11
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$9.38M |
| 2 |
VIVE
VIVEVE MED INC
VIVE
|
+$7.22M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$6.47M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
+$5.39M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$4.74M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$27.2M |
| 2 |
Akebia Therapeutics
AKBA
|
+$7.28M |
| 3 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
+$5.73M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$5.15M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$4.47M |
Sector Composition
| 1 | Healthcare | 92.59% |
| 2 | Technology | 2.14% |
